Calmer Co International Limited · ASX:CCO
Calmer Co International — Shareholder Meeting (November 2020)
21 slides from Calmer Co International's shareholder meeting presentation, Nov 30, 2020
Slide 1: FY20 Annual General Meeting
FY20 ANNUAL GENERAL MEETING ANNUAL GENERAL MEETING
Slide 2: Disclaimer
DISCLAIMER This presentation and any Materials provided (materials) have been prepared by Fiji Kava Limited (Fiji Kava) and contain general information about Fiji Kava activities. By accepting the Materials and attending the Fiji Kava presentation, you agree to be bound by the below terms and condit
Slide 3: Fiji Kava's clear and constant strategy has helped us stay on course
“FIJI KAVA’S CLEAR AND CONSTANT STRATEGY HAS HELPED US STAY ON COURSE THROUGH THIS TURBULENT YEAR” Andrew Kelly - Chair July 2019 ASX Oct 2019 ASX Jan 2020 ASX Apr 2020 ASX July 2020 ASX Oct 2020 ASX FIJI KAVA [ASX:FIJ]
Slide 4: Company Highlights
COMPANY HIGHLIGHTS KEY MILESTONES $764k REVENUE FY20 $4.2m CASH BALANCE $ Market Capitalization High of ~$32m Appointment of Mr Jack Lowenstein to the Board of Fiji Kava as a Non-Executive Director. Highest value-gain of any botanical stock on the ASX for Q1 FY21 at 160.3% and 91.9% versus last year
Slide 5: FY20 revenue grew 320% versus the prior corresponding period
FY20 REVENUE GREW 320% VERSUS THE PRIOR CORRESPONDING PERIOD, DEMONSTRATING LUMPY BUT STEADY REVENUE GROWTH $ REVENUE 000’s % PRODUCT MIX % MARKETS $800 100% 100% $700 90% 90% 80% 80% $600 70% 70% $500 60% 60% $400 50% 50% $300 40% 40% 30% 30% $200 20% 20% $100 10% 10% $0 0% 0% FY19 FY20 H1 H2 H1 H2
Slide 6: Growing Global Health Issues
GROWING GLOBAL HEALTH ISSUES
Slide 7: Over $270 billion spent on consumer health globally in 2020
OVER $270 BILLION SPENT ON CONSUMER HEALTH GLOBALLY IN 2020 & FORECAST TO GROW AT 2.1% YOY to 2025 10 The global market for ‘Sleep Aid’ supplements is worth $3.7B in 2020 and is expected to grow YOY at 9.3% to 2025 2 Global Insomnia Market estimated to reach $5.5 billion by 2023 3 Over 60% of the po
Slide 8: 3,000 years ago, in the middle of the Pacific Ocean, a botanical marvel was found
3,000 YEARS AGO, IN THE MIDDLE OF THE PACIFIC OCEAN. A BOTANICAL MARVEL WAS FOUND. KAVA A HUMBLE ROOT WITH MAGICAL PROPERTIES.
Slide 9: Fiji Kava Noble Kava Supply Chain Excellence
FIJI KAVA [ASX:FIJ] NOBLE KAVA SUPPLY CHAIN EXCELLENCE MEDICINAL KAVA HEALTH & WELLNESS GROWING AVAILABILITY OF FIJIAN NOBLE KAVA COMPANY WHICH PRODUCES NATURAL ‘NOBLE KAVA’ PRODUCTS FOR THE COMPLEMENTARY AND ALTERNATIVE INNOVATION & PRODUCT DEVELOPMENT MEDICINE MARKET MEDICINAL BENEFITS
Slide 10: Supply Chain Excellence
SUPE Ly CHAI EXCELLENCE
Slide 11: Fiji Kava vertical integrated supply chain provides trust & transparency for customers
FIJI KAVA VERTICAL INTEGRATED SUPPLY CHAIN PROVIDES UNPARRALLED TRUST & TRANSPARENCY FOR CUSTOMERS Fiji Kava only grow cultivars are of Noble variety, a superior form of Kava Estate and tissue culture laboratory provides standardisation of Noble Kava varieties, which have the desirable kavalactone p
Slide 12: Innovation & Product Development
Slide 13: New formats providing consumers with safe natural treatments for sleep, anxiety & muscle relaxation
NEW FORMATS PROVIDING CONSUMERS WITH SAFE NATURAL TREATMENTS FOR SLEEP, ANXIETY & MUSCLE RELAXATION RELATED ISSUES 'Sleep', 'Mind’ & 'Body’ innovation strategy, including: NEW Fiji Kava ‘Noble Calm’ vegan hard capsules combining Fiji Kava’s Noble Kava and Rhodiola rosea to calm the nerves, help rela
Slide 14: Growing Availability of Fijian Noble Kava
‘OF FUIAN. NOBLE KAVA
Slide 15: Availability at Coles, license agreement with BioCeuticals and strong partner secured for China
AVAILABILITY AT COLES, LICENSE AGREEMENT WITH BIOCEUTICALS AND STRONG PARTNER SECURED FOR CHINA Yuan Long Yato Memorandum of Understanding to explore the marketing & distribution of Fiji Kava products to Chinese online platforms & direct networks PuMate (Shanghai) Limited partnership to enter the Ch
Slide 16: Medicinal Benefits
Slide 17: Fiji Kava continues to build awareness of the benefits as a safe natural alternative
FIJI KAVA CONTINUES TO BUILD AWARENESS OF THE BENEFITS AS A SAFE NATURAL ALTERNATIVE TO MEDICATIONS NEW look packing ‘Noble Sleep’, ‘Noble Calm’ & ‘Noble Body’ Fiji Kava's Chief Scientific Advisor, Professor Jerome Sarris, continued work with the National Institute of Complementary Medicines (NICM)
Slide 18: Before using Fiji Kava Noble Calm I had crippling social anxiety symptoms
BEFORE USING FIJI KAVA NOBLE CALM I HAD CRIPPLING SOCIAL ANXIETY SYMPTOMS, WITH AN UNCOMFORTABLE "ANXIETY CHATTER" IN MY HEAD 24/7 CAUSING ME TO MAKE EXCUSES NOT TO HANG OUT WITH FRIENDS, CAUSE ISSUES SLEEPING AND OVERALL IMPAIRING MY QUALITY OF LIFE. NOBLE CALM SIGNIFICANTLY REDUCED THAT ANXIETY CH
Slide 19: Despite current macro environments, Fiji Kava is well positioned for long term strategic growth
REFERENCE DOCUMENT DESPITE CURRENT MACRO ENVIROMENTS, FIJI KAVA IS WELL POSITIONED FOR LONG TERM STRATEGIC GROWTH Fiji Kava’s value proposition is unique with its integrated supply chain, value added processing and branded focuses Growing global complementary & alternative medicine market continues
Slide 20: Investor Roadshow (November 2019)
Investor Roadshow (November 2019)
Slide 21: Appendix
APPENDIX ASX www.asx.com.au : 27 November 2020 1 Bioshares Edition 863, 5th October 2020 2 Euromonitor Global Sleep Aids Analysis Nov 2020 3 www.alliedmarketresearch.com/insomnia-market 4 Euromonitor Global Health Report Oct 2020 5 Anxiety Disorders And Depression Treatment Market Analysis By Produc
Calmer Co International — Shareholder Meeting (November 2020) on 6ix